Donor-conceived adults have higher incidence of immunology diseases

September 23, 2020

Adults conceived through sperm donation reported higher frequencies of allergies, type 1 diabetes and other autoimmune conditions in a world-first study that examined the long term health outcomes of donor-conceived people.

The study was conducted by Flinders University's Caring Futures Institute, led by researcher Damian Adams, and published in the Journal of Developmental Origins of Health and Disease. It looked at 272 donor-conceived adult participants from around the world together with 877 who were conceived naturally.

Results revealed that for most health outcomes, donor sperm conceived adults reported no significant difference to participants born through natural conception.

However, donor sperm conceived adults had seven times more type 1 diabetes diagnoses than naturally conceived adults, together with double the incidence of thyroid disease, acute bronchitis and sleep apnoea; and a 45% incidence of allergies compared to 35% in the naturally conceived population.

Mr Adams says most of the health conditions reported by donor conceived people had an immunological basis, suggesting an alteration to their immunological systems.

"What may potentially be driving this is the maternal complication of preeclampsia, which has increased incidences associated with the use of donated gametes (sex cells)," he says.

"Preeclampsia is an extremely serious condition that is mediated by the immune system. Research has shown that children born from a pregnancy complicated by preeclampsia have altered epigenetic profiles including links with an altered immune system."

Mr Adams is a PhD candidate at Flinders University, whose interest in the health outcomes of donor-conceived people was sparked by vast knowledge gaps in the area.

His supervisors include Flinders University Professor Sheryl de Lacey, who has a clinical background in infertility and assisted reproductive technology.

She says the use of donor gametes has been cloaked in secrecy and abetted by anonymity, with pregnancies assumed to be no different to natural conceptions.

"Being aware of an increased risk of pre-eclampsia in pregnancy and the implications for children in adulthood holds the potential to empower women beyond their pregnancy," Professor de Lacey says.

"For parents, this unique study provides important information that informs their decision of whether to disclose conception means to their child, and to choose the health care they receive.

For donor conceived people, having this information may improve vigilance in preventative health behaviours."

Mr Adams says donor-conceived people are a hard to reach population, with research consistently showing that the majority do not know they were conceived by sperm donation.

"We had to implement six different recruitment strategies to attract the sample size we achieved," he says.

The majority of participants were from Australia, the United States, the United Kingdom, Belgium and the Netherlands.

Those conceived by donor or through natural conception were matched for age, sex, height, smoking habits, alcohol consumption, exercise and fertility.

"This study was preceded by our systematic review of the literature, where we noted a dearth of studies investigating the perinatal and long-term health outcomes of donor sperm treatments, despite the technique being used for almost 140 years," Mr Adams says.
Media contacts:

Damian Adams, Flinders University researcher
E: T +61 417 848 203

Megan Andrews, Media and Communications
E: T: +61 8 8201 2916 M: +61 487 499 004

Flinders University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to